Dietary treatment is more effective than medications in irritable bowel syndrome (IBS). These are the findings of a study conducted at the University of Gothenburg.
Dupixent receives FDA approval as first CRSwNP treatment
CRSwNP is a chronic inflammatory disease of the upper airway. Credit: Luisella Planeta LOVE PEACE 💛💙 from Pixabay. The US Food and Drug Administration (FDA)
September 16, 2024